Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-7.31 Cr₹52 Cr₹48 Cr₹37 Cr₹6.13 Cr

What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of BALAXI PHARMACEUTICALS is ₹-7.31 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-7.31 Cr
Mar2024₹52 Cr
Mar2023₹48 Cr
Mar2022₹37 Cr
Mar2021₹6.13 Cr

How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-7.31 Cr
Negative
Mar2024 ₹52 Cr
7.39
Mar2023 ₹48 Cr
29.41
Mar2022 ₹37 Cr
507.51
Mar2021 ₹6.13 Cr -

Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹126.8 Cr -3.9% -18.3% -67.4% Stock Analytics
ADANI ENTERPRISES ₹290,828.0 Cr 11.6% -2.1% 1.7% Stock Analytics
REDINGTON ₹21,252.5 Cr -0% -5.6% 31.1% Stock Analytics
MMTC ₹9,913.5 Cr 2% -5.9% -6.6% Stock Analytics
HONASA CONSUMER ₹9,561.0 Cr 3.6% -5% 22.8% Stock Analytics
LLOYDS ENTERPRISES ₹8,942.5 Cr 4.2% -10.5% 25.7% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-3.9%

-18.3%

-67.4%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses